Table 3. Five-year relative survival ratios (RSRs) and 5-year excess hazard ratios (EHRs) in relation to high-risk human papillomavirus (hrHPV) status in the 2 main histological types of invasive cervical cancer.

Histological type and hrHPV status	Cases (n = 2,635)	Deaths (n = 1,021)	5-year RSR (95% CI)	5-year EHR (95% CI)
				Crude	Adjusted*
SCC, hrHPV−	374	190	0.59 (0.53–0.64)	Ref	Ref
SCC, hrHPV+	1,735	665	0.73 (0.70–0.75)	0.56 (0.46–0.68)	0.68 (0.56–0.82)
AC, hrHPV−	116	81	0.45 (0.35–0.55)	1.48 (1.09–2.01)	1.44 (1.07–1.97)
AC, hrHPV+	410	85	0.87 (0.83–0.90)	0.23 (0.17–0.33)	0.61 (0.43–0.87)

Adenosquamous cell carcinoma (n = 119) and other rare carcinomas (n = 91) are not included in this analysis.

*EHRs were adjusted for age at cancer diagnosis as a spline term with 5 degrees of freedom, time since cancer diagnosis in 1-year bands, International Federation of Gynecology and Obstetrics (FIGO) stage, and education.

AC, adenocarcinoma; SCC, squamous cell carcinoma.